Modification of pancreatic carcinogenesis in the hamster model. 6. The effect of ductal ligation and excision.
The effect of ligation and excision of the pancreatic duct in pancreatic carcinogenesis was examined in the hamster model. Animals were treated with a single dose (20 mg/kg body weight) of N-nitrosobis(2-oxopropyl)amine (BOP) either immediately (Group 1) or on Days 1 (Group 2), 3 (Group 3) or 7 (Group 4) after ligation and excision of the duct of the splenic lobe. Group 5 received BOP shortly after laparoscopy, and Group 6 consisted of BOP-treated controls. All hamsters were killed 46 weeks after BOP treatment. The results showed that despite advanced atrophy of the splenic lobe distal to the excised duct in Groups 1-4, some hamsters in Groups 2, 3, and 4 showed hyperplasia, dysplasia, and increased mitotic activities of ductal and ductular cells. However, carcinomas in the duct-excised atrophic lobe were found only in Groups 1-3. These data indicate that BOP carcinogenesis is mediated through blood circulation, and that cancer development is not inhibited in the duct-excised lobe for up to 3 days after surgery. However, in the entire pancreas, a significant reduction in tumor incidence was seen when the carcinogen was given immediately, or to a lesser extent, 1 day after surgery, regardless of whether or not excision was made. On the contrary, BOP, when given 3 and 7 days after duct excision, enhanced tumor development in the nonexcised (intact) pancreas, compared with other test groups and with BOP controls. Both inhibition and enhancement seemed due to a proportional decrease and increase, respectively, of BOP-responsive cells throughout the intact pancreas.
D000818:Animals; D006224:Cricetinae; D004195:Disease Models, Animal; D006965:Hyperplasia; D008026:Ligation; D008647:Mesocricetus; D008938:Mitosis; D009602:Nitrosamines; D010180:Pancreatectomy; D010183:Pancreatic Ducts / Q000601:surgery* / Q000648:ultrastructure; D010190:Pancreatic Neoplasms / Q000139:chemically induced* / Q000648:ultrastructure
D009602:Nitrosamines; C013622:nitrosobis(2-oxopropyl)amine